Your Health, We Care

Home >Drug List>Mobocertinib>Indications of Mobocertinib

Exkivity(Mobocertinib)

Release date: 2026-01-06 10:46:58     Recommended: 107

Exkivity is suitable for specific non-small cell lung cancer(NSCLC).